Synonyms: compound 139 [WO2019160882A1] | GS-4224 | GS4224 | PD-1/PD-L1-IN 7
Compound class:
Synthetic organic
Comment: We obtained the chemical structure for evixapodlin from WHO Proposed list 125 of July 2021. The INN record describes it as a programmed cell death ligand 1 (PD-L1) inhibitor. Evixapodlin is one of the chemical structures that is claimed in Gilead Sciences' patent WO2019160882A1 (compound number 139) [1]. It was developed as an alternative to monocloncal antibody PD-L1/PD-1 interaction inhibitors, for potential anticancer and antiviral activities. First disclosures at the ACS meeting in Chicago in 2022 mapped evixapodlin to Gilead's clinical lead GS-4224. GS-4224 is orally bioavailable.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one |
International Nonproprietary Names ![]() |
|
INN number | INN |
11804 | evixapodlin |
Synonyms ![]() |
compound 139 [WO2019160882A1] | GS-4224 | GS4224 | PD-1/PD-L1-IN 7 |
Database Links ![]() |
|
BindingDB Ligand | 451999 |
CAS Registry No. | 2374856-75-2 (source: WHO INN record) |
GtoPdb PubChem SID | 442878710 |
PubChem CID | 139415912 |
Search Google for chemical match using the InChIKey | OIIOPWHTJZYKIL-PMACEKPBSA-N |
Search Google for chemicals with the same backbone | OIIOPWHTJZYKIL |
Search PubMed clinical trials | evixapodlin |
Search PubMed titles | evixapodlin |
Search PubMed titles/abstracts | evixapodlin |
UniChem Compound Search for chemical match using the InChIKey | OIIOPWHTJZYKIL-PMACEKPBSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OIIOPWHTJZYKIL-PMACEKPBSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Evixapodlin (links to external site)
Cat. No. HY-138407 |